News, Media & Events
Keep Up To Date With MAC
How can advancements in research help us better understand menopause and provide personalised treatments for managing symptoms?
With insight from Dr Abiramy Yogendran Menopause is a natural biological process that marks the end of a woman’s reproductive
Kariya Pharmaceuticals has received approval from the MHRA for their Clinical Trial Application (CTA) related to their leading Parkinson’s drug
Psoriasis is a chronic skin disease that affects millions of people worldwide causing uncomfortable and itchy scaly patches primarily on
Did you know we provide an array of scientific solutions for our sponsors? One of these bespoke and highly interesting
Social connections are vital for our health and wellbeing. With the advent of the internet, smartphones, and social media, it’s
Jessica Baskin Taylor, MAC’s Director of Operations for North America, has been instrumental in the local team that is reviving
Read our white paper to find out more Last month we attended the 2023 CDISC Europe Interchange where MAC Principal
To continue to meet the research needs of our clients and their patients across the globe, MAC Clinical Research has
MAC enters partnership with Kariya Pharmaceuticals with the commencement of Phase I trial for Parkinson’s drug. We are excited to
Parkinson’s disease (PD) is a progressive movement disorder of the nervous system. Like a fingerprint, disease presentation is different in
At MAC, we welcome the recent update from the MHRA announcing that they will streamline clinical trial approvals in its
Martyn Deverell, Principal SAS Programmer at MAC Clinical Research will be speaking at the 2023 CDISC Europe Interchange taking place
We are excited to share that our Early Phase Unit in Manchester dosed the first participant in Small Pharma’s first-in-human
We’re proud to share that Hannah Gillis, Head of Data Management has been selected as a finalist for this year’s
In recognition of the International Day of Women and Girls in Science on February 11th, I had the opportunity to
The placebo response or the placebo effect. We hear about it a lot, but what happens in practise? Let’s unravel
With International Day of Women and Girls in Science taking place in February, we want to showcase some of the
At MAC we have expertise in a wide range of different areas including Men and Women’s Health. One of these
SmallPharma, a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions has enlisted MAC to support a new
At MAC, we have a proud history of establishing one of the UK’s first ever memory clinics back in 1988.
The next generation of treatment? Could psychedelic research be a promising new step in treating mental health disorders like depression,
The Transatlantic Growth campaign (TAG) is an annual campaign that highlights and celebrates businesses that demonstrate growth and investment on
Dr Peter Dewland, Senior Director of Early Phase Research has been awarded the Faculty of Pharmaceutical Medicine President’s Medal.
MAC’s Senior Director of Early Phase Research, Dr Peter Dewland, has been awarded the Faculty of Pharmaceutical Medicine President’s Medal.
PRESS RELEASE: Initiator Pharma reports positive Phase IIa clinical data for IPED2015 in patients with severe Erectile Dysfunction
Initiator Pharma A/S, a clinical-stage biotech company that is developing a novel treatment of erectile dysfunction (ED), today announced statistically significant results on key efficacy endpoints in severe ED patients after a single administration of IPED2015. Moreover, no observations of critical adverse events were recorded.
Photo gallery from CTAD 2018 in Barcelona on 25th October.
PRESS RELEASE: MAC Clinical Research expands its Global Site Network and access to patients in Australia and Asia Pacific regions
October 24, 2018 MANCHESTER, ENGLAND Across every clinical trial, Pharma and Biotech have a dire need to access patients in efficient
MAC’s GMP pharmacy manufacturing department currently supports our MHRA accredited Phase 1 research centre in Manchester and late phase dedicated
Defying Dementia is raising funds for Dementia research.
MAC is very proud to announce that Dr Mark Dale (CEO) has been awarded Honorary Membership of the Faculty of
MAC Neuroscience Centre of excellence, the early phase division of MAC Clinical Research, has been awarded Accreditation from the Medicines and Healthcare products Regulatory Agency (MHRA).
MAC will be exhibiting at this year’s Exploratory Clinical Development World Congress in Berlin 26th – 27th October 2016.
MAC’s Chief Research and Development Officer, Dr John Connell will be speaking at the 35th Annual Scientific Meeting of the
A new drug developed by Lancaster University which may help to prevent the early stages of Alzheimer’s disease is to enter clinical trials. Lancaster University has filed a patent application for the drug, and it will be progressing into clinical trials run by the north-west research company MAC Clinical Research.
MAC is delighted to announce that it has won the highly coveted Health and Care Business of the Year Award
MAC Clinical Research has opened a new phase I/IIa clinic at Citylabs in Manchester, expanding its phase I services in
We are delighted to annouce that MAC has been shortlisted for Bionow’s Technical Service of the Year Award. The Bionow awards celebrate and
We are delighted to welcome Dr John Connell to MAC who will lead our pharmacodynamic offering. Dr Connell completed his
MAC’s pain experts were on hand at the 15th World Congress on Pain this week. The team met with many
THCV improves glycaemic control in Type 2 Diabetes “Diabetes is at crisis levels”: The International Diabetes Foundation calculate that 366
MAC had a team of Business Development personnel and Scientists at this years Partnerships in Clinical Trials Congress in Vienna.
Members of the MAC Blackpool team were present to support the 2013 Fylde Coast Health Mela on Saturday 5th October, which was held in the Winter Gardens in Blackpool. This was the first ever health Mela to be held in the area and MAC were happy to aid its cause.
MAC Clinical Research has recently completed the installation of a state-of-the-art aseptic suite at its flagship research site in Manchester.
Mark Dale, CEO of MAC Clinical Research wins and Institute of Directors Award for Innovation.
MAC is delighted and very proud to have received the Queen’s Award in recognition of MAC’s trade achievements. The Award is a marvellous acknowledgement our Company’s business development in the clinical research industry. (Image: Her Majesty Queen Elizabeth II greets winners of the Queen’s Award
Cathy Jepson of MAC meets the Queen)
CliniSafe® has won the 2010 SCRIP award for Best Technological Development in Clinical Trials. SCRIP Intelligence – the leading news, data and information service for the global pharmaceutical industry – hosted the 6th Annual SCRIP Awards on 4th November at London’s Grosvenor House Hotel. More than 500 people were present at the industry’s most prestigious and hotly-contested awards event.
MAC’S Cathy Jepson (Centre) Represents CliniSafe To Present Quintiles With The 2010 SCRIP Award For Best Contract Research Organisation
CliniSafe® sponsors the 2010 SCRIP Award for Best Contract Research Organisation.
Follow MAC Clinical Research on social media to keep up to date with our latest news and updates.